Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Mubarak Labaran Liman has overcome the death of his father and a scarcity of resources to develop a thriving...
Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino...
After several previous attempts to repeal the Affordable Care Act (ACA) failed, another attempt is nearing a vote in...
The AACR is holding a special conference, Advances in Modeling Cancer in Mice: Technology, Biology, and Beyond, in Orlando,...
The flurry of treatments approved by the U.S. Food and Drug Administration (FDA) for treating hematological malignancies continued last...
Today, the American Association for Cancer Research (AACR) released its seventh annual Cancer Progress Report. The report highlights how...